DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Ebert PJR, Cheung J, Yang Y. et al.
MAP kinase inhibition promotes T Cell and anti-tumor activity in combination with PD-L1 checkpoint blockade.
Immunity 2016;
44 (03) 609-621
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.